Pill imprint M 14 has been identified as Methotrexate sodium 2.5 mg.
Methotrexate is used in the treatment of rheumatoid arthritis; psoriasis; brain tumor; breast cancer; cervical cancer (and more), and belongs to the drug classes antimetabolites, antipsoriatics, antirheumatics. Not for use in pregnancy.
Methotrexate 2.5 mg is not subject to the Controlled Substances Act.
Search for questions
Still looking for answers? Try searching for what you seek or ask your own question.